New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
15:25 EDTPVCT, PVCTProvectus Pharmaceuticals to host conference call
Conference Call to provide updates on the Phase 3 clinical trial of PV-10 will be held on June 19 at 4 pm. Webcast Link
News For PVCT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
06:02 EDTPVCTProvectus receives notification of allowance for PV-10 in China
Provectus Biopharmaceuticals announced that it has received notification of allowance from the Chinese Patent Office for its patent application protecting the synthetic process used to produce the small molecule Rose Bengal, the active pharmaceutical ingredient in PV-10, the Company's lead oncology drug candidate.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use